About Carthera
Carthera is a company based in Paris (France) founded in 2010. It operates as a HealthTech. Carthera has raised $55.06 million across 5 funding rounds from investors including Bpifrance, European Union and Unorthodox Ventures. Carthera offers products and services including SonoCloud. Carthera operates in a competitive market with competitors including Insightec, HistoSonics, Profound Medical, Theraclion and SONIRE Therapeutics, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Carthera Incorporated
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$55.06 M (USD)
in 5 rounds
-
Latest Funding Round
$4.84 M (USD), Series B
Dec 11, 2023
-
Investors
Bpifrance
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Carthera
Carthera offers a comprehensive portfolio of products and services, including SonoCloud.
Ultrasound device opens blood-brain barrier for therapy.
People of Carthera
Unlock access to complete
Unlock access to complete
Funding Insights of Carthera
Carthera has successfully raised a total of $55.06M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $4.84 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Carthera
Carthera has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, European Union and Unorthodox Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in medical and construction technology.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Carthera
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Carthera
Investment portfolio details for Carthera
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Carthera
Detailed financials for Carthera
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Carthera Comparisons
Peer comparison for Carthera
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Carthera
Carthera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insightec, HistoSonics, Profound Medical, Theraclion and SONIRE Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
|
|
| Locked | Locked | Locked |
Tissue ablation is achieved through non-invasive ultrasound Histotripsy technology.
|
|
| Locked | Locked | Locked |
Image-guided prostate ablation systems for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Provider of non-invasive robotic ultrasound therapy devices
|
|
| Locked | Locked | Locked |
High-intensity focused ultrasound systems for targeted cancer treatments are developed.
|
Detailed competitors of Carthera
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Carthera
Complete news archive for Carthera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Carthera
Carthera was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Carthera is headquartered in Paris, France.
Carthera is a funded company, having raised a total of $55.06M across 5 funding rounds to date.
Carthera is engaged in the development of innovative ultrasound-based medical devices aimed at treating severe brain disorders. The companys primary focus is on oncology indications such as glioblastoma and brain metastases, while also exploring solutions for neurodegenerative conditions like Alzheimers Disease. Their flagship product, SonoCloud, is designed to temporarily open the blood-brain barrier using low-intensity pulsed ultrasound, enhancing the delivery of therapeutic agents like chemotherapy and immunotherapy to the brain. Clinical trials are being conducted to validate the efficacy and safety of this technology across multiple international locations. Carthera collaborates with pharmaceutical partners to address high unmet medical needs in brain tumor treatments and other central nervous system diseases.
Carthera's top competitors include Insightec, HistoSonics and Profound Medical.
Carthera offers SonoCloud.
Carthera has 10 investors. Key investors include Bpifrance, European Union, Unorthodox Ventures, Supernova Invest, and Heritiers Saint-Genys.